DEA Adds Metonitazene to Schedule I Drug List
The Drug Enforcement Administration permanently placed the synthetic benzimidazol-opioid metonitazene on Schedule I of the Controlled Substances Act, it said in a final order released Aug. 17. The substance had already been temporarily listed in Schedule I since 2022 (see…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
2204110029). The final order is set to take effect Sept. 18.